Acquired by Thermo Fisher Scientific.
PharmaFluidics is a spin-off company of the Vrije Universiteit Brussel that developed a complementary range of reversed-phase chromatography columns for systems biology and biopharma applications.
THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.
Indigo is developing an implantable sensor that allows to continuously measure glucose and other metabolites for up to two years.
Flindr aims to restore a patient’s impaired immune response to cancer
